Tirona R G, Leake B F, Merino G, Kim R B
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6602, USA.
J Biol Chem. 2001 Sep 21;276(38):35669-75. doi: 10.1074/jbc.M103792200. Epub 2001 Jul 26.
The human organic anion transporting polypeptide-C (OATP-C) (gene SLC21A6) is a liver-specific transporter importantly involved in the hepatocellular uptake of a variety of endogenous and foreign chemicals. In this study, we demonstrate the presence of multiple functionally relevant single-nucleotide polymorphisms (SNPs) in OATP-C in a population of African- and European-Americans. Moreover, examination of 14 nonsynonymous polymorphisms indicated that genotypic frequencies were dependent on race. Functional assessment of 16 OATP-C alleles in vitro revealed that several variants exhibited markedly reduced uptake of the OATP-C substrates estrone sulfate and estradiol 17beta-d-glucuronide. Specifically, alterations in transport were associated with SNPs that introduce amino acid changes within the transmembrane-spanning domains (T217C (Phe-73 --> Leu), T245C (Val-82 --> Ala), T521C (Val-174 --> Ala), and T1058C (Ile-353 --> Thr)) and also with those that modify extracellular loop 5 (A1294G (Asn-432 --> Asp), A1385G (Asp-462 --> Gly), and A1463C (Gly-488 --> Ala)). Cell surface biotinylation experiments indicated that the altered transport activity of some OATP-C variants was due, in part, to decreased plasma membrane expression. Given the relatively high genotypic frequency of the T521C (14%) transition in European-Americans and the G1463C (9%) transversion in African-Americans, SNPs in OATP-C may represent a heretofore unrecognized factor influencing drug disposition.
人类有机阴离子转运多肽-C(OATP-C)(基因SLC21A6)是一种肝脏特异性转运蛋白,在肝细胞摄取多种内源性和外源性化学物质过程中发挥重要作用。在本研究中,我们证实在非裔美国人和欧裔美国人人群的OATP-C中存在多个具有功能相关性的单核苷酸多态性(SNP)。此外,对14个非同义多态性的检测表明,基因型频率取决于种族。对16个OATP-C等位基因进行的体外功能评估显示,几种变体对OATP-C底物硫酸雌酮和17β -D-葡萄糖醛酸雌二醇的摄取显著减少。具体而言,转运改变与跨膜结构域内引入氨基酸变化的SNP(T217C(Phe-73→Leu)、T245C(Val-82→Ala)、T521C(Val-174→Ala)和T1058C(Ile-353→Thr))以及修饰细胞外环5的SNP(A1294G(Asn-432→Asp)、A1385G(Asp-462→Gly)和A1463C(Gly-488→Ala))有关。细胞表面生物素化实验表明,一些OATP-C变体转运活性的改变部分归因于质膜表达的降低。鉴于欧裔美国人中T521C(14%)转换和非裔美国人中G1463C(9%)颠换的基因型频率相对较高,OATP-C中的SNP可能是一个此前未被认识到的影响药物处置的因素。